ZILEBESIRAN 3'-MODIFICATION
Chemical
FDA Substance Registry (openFDA)
Chemical Identification
| INCI Name | [(2S,4R)-1-[12-[[1-[3-[3-[5-[(2R,3R,4R,5R,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypentanoylamino]propylamino]-3-oxopropoxy]-2-[[3-[3-[5-[(2R,3R,4R,5R,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypentanoylamino]propylamino]-3-oxopropoxy]methyl]-3-[3-[3-[5-[(2R,3R,4R,5R,6R)-3-acetamido-4,5-dihydroxy-6-methyloxan-2-yl]oxypentanoylamino]propylamino]-3-oxopropoxy]propan-2-yl]amino]-12-oxododecanoyl]-4-hydroxypyrrolidin-2-yl]methyl [(2R,3R,4R,5R)-5-(6-aminopurin-9-yl)-2-(hydroxymethyl)-4-methoxyoxolan-3-yl] hydrogen phosphate |
|---|---|
| PubChem CID | 155804729 |
| Molecular Formula | C89H153N16O36P |
| InChIKey | InChI=1S/C89H153N16O36P/c1- |
| SMILES | C[C@@H]1[C@@H]([C@@H]([C@H]([C@@H](O1)OCCCCC(=O)NCCCNC(=O)CCOCC(COCCC(=O)NCCCNC(=O)CCCCO[C@H]2[C@@H]([C@H]([C@H]([C@H](O2)CO)O)O)NC(=O)C)(COCCC(=O)NCCCNC(=O)CCCCO[C@H]3[C@@H]([C@H]([C@H]([C@H](O3)CO)O)O)NC(=O)C)NC(=O)CCCCCCCCCCC(=O)N4C[C@@H](C[C@H]4COP(=O)(O)O[C@@H]5[C@H](O[C@H]([C@@H]5OC)N6C=NC7=C(N=CN=C76)N)CO)O)NC(=O)C)O)O |
Data Sources (1)
| Source | Source ID | Name in Source | Properties |
|---|---|---|---|
| FDA Substance Registry (openFDA) | UM4X8S48E7 |
ZILEBESIRAN 3'-MODIFICATION |
PUBCHEM: 155804729 FDA UNII: UM4X8S48E7 |
Record Info
| ID | Y8UEWPDhmz3wcn7yhS3Ghj |
|---|---|
| Created | April 10, 2026, 11:03 p.m. |
| Modified | April 10, 2026, 11:03 p.m. |
| Enriched | April 11, 2026, 12:09 a.m. |
| Data Source | FDA Substance Registry (openFDA) |